Single-agent belantamab mafodotin in patients with relapsed/refractory multiple myeloma: Final analysis of the DREAMM-2 trial
暂无分享，去创建一个
S. Lonial | S. Trudel | N. Callander | D. Sborov | A. Chari | M. Hultcrantz | J. Opalinska | A. Suvannasankha | R. Popat | A. Badros | M. Chaudhry | I. Gupta | A. McKeown | B. Gorsh | Al-Ola Abdallah | K. Kortüm | E. Lewis | Shawn Hakim | Bharat Bhushan | Ajay K. Nooka | A. Cohen | Hans C Lee | Edward N. Libby | Paul G. Richardson